D Campbell Dewey1, Svjetlana Miocinovic1, Ira Bernstein2, Pravin Khemani1, Richard B Dewey4, Ross Querry3, Shilpa Chitnis1, Richard B Dewey4. 1. Department of Neurology, University of Texas Southwestern Medical Center, United States. 2. Department of Clinical Sciences, University of Texas Southwestern Medical Center, United States. 3. Department of Physical Therapy, University of Texas Southwestern Medical Center, United States. 4. Department of Neurology, University of Texas Southwestern Medical Center, United States. Electronic address: Richard.dewey@utsouthwestern.edu.
Abstract
OBJECTIVE: To assess the suitability of instrumented gait and balance measures for diagnosis and estimation of disease severity in PD. METHODS: Each subject performed iTUG (instrumented Timed-Up-and-Go) and iSway (instrumented Sway) using the APDM(®) Mobility Lab. MDS-UPDRS parts II and III, a postural instability and gait disorder (PIGD) score, the mobility subscale of the PDQ-39, and Hoehn & Yahr stage were measured in the PD cohort. Two sets of gait and balance variables were defined by high correlation with diagnosis or disease severity and were evaluated using multiple linear and logistic regressions, ROC analyses, and t-tests. RESULTS: 135 PD subjects and 66 age-matched controls were evaluated in this prospective cohort study. We found that both iTUG and iSway variables differentiated PD subjects from controls (area under the ROC curve was 0.82 and 0.75 respectively) and correlated with all PD severity measures (R(2) ranging from 0.18 to 0.61). Objective exam-based scores correlated more strongly with iTUG than iSway. The chosen set of iTUG variables was abnormal in very mild disease. Age and gender influenced gait and balance parameters and were therefore controlled in all analyses. INTERPRETATION: Our study identified sets of iTUG and iSway variables which correlate with PD severity measures and differentiate PD subjects from controls. These gait and balance measures could potentially serve as markers of PD progression and are under evaluation for this purpose in the ongoing NIH Parkinson Disease Biomarker Program.
OBJECTIVE: To assess the suitability of instrumented gait and balance measures for diagnosis and estimation of disease severity in PD. METHODS: Each subject performed iTUG (instrumented Timed-Up-and-Go) and iSway (instrumented Sway) using the APDM(®) Mobility Lab. MDS-UPDRS parts II and III, a postural instability and gait disorder (PIGD) score, the mobility subscale of the PDQ-39, and Hoehn & Yahr stage were measured in the PD cohort. Two sets of gait and balance variables were defined by high correlation with diagnosis or disease severity and were evaluated using multiple linear and logistic regressions, ROC analyses, and t-tests. RESULTS: 135 PD subjects and 66 age-matched controls were evaluated in this prospective cohort study. We found that both iTUG and iSway variables differentiated PD subjects from controls (area under the ROC curve was 0.82 and 0.75 respectively) and correlated with all PD severity measures (R(2) ranging from 0.18 to 0.61). Objective exam-based scores correlated more strongly with iTUG than iSway. The chosen set of iTUG variables was abnormal in very mild disease. Age and gender influenced gait and balance parameters and were therefore controlled in all analyses. INTERPRETATION: Our study identified sets of iTUG and iSway variables which correlate with PD severity measures and differentiate PD subjects from controls. These gait and balance measures could potentially serve as markers of PD progression and are under evaluation for this purpose in the ongoing NIH Parkinson Disease Biomarker Program.
Authors: Arash Salarian; Cris Zampieri; Fay B Horak; Patricia Carlson-Kuhta; John G Nutt; Kamiar Aminian Journal: Conf Proc IEEE Eng Med Biol Soc Date: 2009
Authors: Vyom Raval; Kevin P Nguyen; Ashley Gerald; Richard B Dewey; Albert Montillo Journal: Proc IEEE Int Conf Acoust Speech Signal Process Date: 2020-05-14
Authors: Gustavo Christofoletti; Marie E McNeely; Meghan C Campbell; Ryan P Duncan; Gammon M Earhart Journal: Hum Mov Sci Date: 2016-08-20 Impact factor: 2.161
Authors: Katrina Gwinn; Karen K David; Christine Swanson-Fischer; Roger Albin; Coryse St Hillaire-Clarke; Beth-Anne Sieber; Codrin Lungu; F DuBois Bowman; Roy N Alcalay; Debra Babcock; Ted M Dawson; Richard B Dewey; Tatiana Foroud; Dwight German; Xuemei Huang; Vlad Petyuk; Judith A Potashkin; Rachel Saunders-Pullman; Margaret Sutherland; David R Walt; Andrew B West; Jing Zhang; Alice Chen-Plotkin; Clemens R Scherzer; David E Vaillancourt; Liana S Rosenthal Journal: Biomark Med Date: 2017-06-23 Impact factor: 2.851
Authors: Liana S Rosenthal; Daniel Drake; Roy N Alcalay; Debra Babcock; F DuBois Bowman; Alice Chen-Plotkin; Ted M Dawson; Richard B Dewey; Dwight C German; Xuemei Huang; Barry Landin; Matthew McAuliffe; Vladislav A Petyuk; Clemens R Scherzer; Coryse St Hillaire-Clarke; Beth-Anne Sieber; Margaret Sutherland; Chi Tarn; Andrew West; David Vaillancourt; Jing Zhang; Katrina Gwinn Journal: Mov Disord Date: 2015-10-07 Impact factor: 10.338